Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q Ping

Showing results (211-220 of 231) with videos related to

Pageof 24
Sort By:
Plos One|November 10, 2012
L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitroHongbiao Huang, Ningning Liu, Haiping Guo, et al.
The Prostate|February 7, 2014
Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancerChristine Neslund-Dudas, Albert M Levin, Andrew Rundle, et al.
Frontiers in Bioscience : a Journal and Virtual Library|March 17, 2005
Structure-activity relationships OF N-methylthiolated beta-lactam antibiotics with C3 substitutions and their selective induction of apoptosis in human cancer cellsDeborah J Kuhn, Yang Wang, Vesna Minic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2013
Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulationXianping Shi, Xin Chen, Xiaofen Li, et al.
Oncotarget|September 7, 2014
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanismsXin Chen, Xianping Shi, Chong Zhao, et al.
Nutrients|November 8, 2018
Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer CellsJoshua R Heyza, Sanjeevani Arora, Hao Zhang, et al.
Cancer Letters|January 11, 2011
Gambogic acid enhances proteasome inhibitor-induced anticancer activityHongbiao Huang, Di Chen, Shujue Li, et al.
Plos One|January 4, 2013
HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivoHongbiao Huang, Ningning Liu, Changshan Yang, et al.
Cancer Causes & Control : CCC|May 8, 2014
Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American menChristine Neslund-Dudas, Albert M Levin, Jennifer L Beebe-Dimmer, et al.
European Journal of Medicinal Chemistry|June 16, 2018
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancerValentina Gambini, Martina Tilio, Eunice Wairimu Maina, et al.
Pageof 24

Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Plos One|November 10, 2012
L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitroHongbiao Huang, Ningning Liu, Haiping Guo, et al.
The Prostate|February 7, 2014
Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancerChristine Neslund-Dudas, Albert M Levin, Andrew Rundle, et al.
Frontiers in Bioscience : a Journal and Virtual Library|March 17, 2005
Structure-activity relationships OF N-methylthiolated beta-lactam antibiotics with C3 substitutions and their selective induction of apoptosis in human cancer cellsDeborah J Kuhn, Yang Wang, Vesna Minic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2013
Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulationXianping Shi, Xin Chen, Xiaofen Li, et al.
Oncotarget|September 7, 2014
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanismsXin Chen, Xianping Shi, Chong Zhao, et al.
Nutrients|November 8, 2018
Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer CellsJoshua R Heyza, Sanjeevani Arora, Hao Zhang, et al.
Cancer Letters|January 11, 2011
Gambogic acid enhances proteasome inhibitor-induced anticancer activityHongbiao Huang, Di Chen, Shujue Li, et al.
Plos One|January 4, 2013
HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivoHongbiao Huang, Ningning Liu, Changshan Yang, et al.
Cancer Causes & Control : CCC|May 8, 2014
Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American menChristine Neslund-Dudas, Albert M Levin, Jennifer L Beebe-Dimmer, et al.
European Journal of Medicinal Chemistry|June 16, 2018
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancerValentina Gambini, Martina Tilio, Eunice Wairimu Maina, et al.
Pageof 24